What is Regeneron Pharmaceuticals's EYLEA — revenue?

Regeneron Pharmaceuticals (REGN) reported EYLEA — revenue of $412.2M in Q2 2026.

What does EYLEA — revenue mean?

This metric represents the total net sales generated from a specific pharmaceutical product line after accounting for all sales-related deductions such as rebates, discounts, and returns. It serves as a primary indicator of the product's market adoption, competitive positioning, and lifecycle maturity within the company's therapeutic portfolio. Monitoring this revenue stream is essential for assessing the financial contribution of key assets to the firm's overall top-line performance.

Regeneron Pharmaceuticals REGN EYLEA — Revenue

Similar metrics at other companies

ABBVElahere — Net revenues

$198M+10.6%

ABBVEpkinly — Net revenues

$83M+62.7%

HYEMEA — Revenue

$172.33M-15.7%

PFEEliquis — Revenues:

$2.17B+12.6%

XER

XERSKeveyis — Product revenue, net

$11.89M+4.0%

JNJERLEADA — Sales to customers (Note 9)

$995M+9.6%

Other financials

Income statement

See full

Revenue$4.3B+16.7%

Operating income$1.3B+19.8%

Net income$1.3B-6.8%

EPS (diluted)$12.23-4.5%

Balance sheet

See full

Cash & equivalents$2.5B+22.3%

Total debt$2.7B+0.1%

Total equity$31.7B+5.9%

Total assets$41.7B+9.2%

Cash flow

See full

Operating cash flow$813.0M-29.0%

CapEx$240.2M+9.7%

Free cash flow$572.8M-38.1%

Valuation

See full

Market cap$72.88B+21.8%

Enterprise value$73.12B+20.8%

P/E16.8×+3.4×

P/S4.7×+0.5×

Profitability

See full

Gross margin94.9%—

Operating margin24.7%-2.3pp

Net margin27.9%-3.5pp

FCF margin24.2%-2.9pp

Returns & leverage

See full

Return on equity14%-1.3pp

Debt / equity0.1×0.0×

Current ratio3.3×-1.3×

Where this comes from

Reported directly by Regeneron Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Regeneron Pharmaceuticals’s 10-Q, filed July 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Regeneron Pharmaceuticals's eylea — revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Regeneron Pharmaceuticals's EYLEA — revenue?: Regeneron Pharmaceuticals (REGN) reported EYLEA — revenue of $412.2M in Q2 2026.
What does EYLEA — revenue mean?: This metric represents the total net sales generated from a specific pharmaceutical product line after accounting for all sales-related deductions such as rebates, discounts, and returns. It serves as a primary indicator of the product's market adoption, competitive positioning, and lifecycle maturity within the company's therapeutic portfolio. Monitoring this revenue stream is essential for assessing the financial contribution of key assets to the firm's overall top-line performance.